Yesterday, Prilenia hosted a webinar updating on the Phase III trial with Pridopidine. Thank you to everyone who join and a special thanks to our speakers, Michael Hayden, Andrew Feigin, Ralf Reilman and Anne Rosser and also to Dina de Sousa for European Huntington Association. Stay tuned to see more events during May Awareness Month!
News
SOM Biotech completes the recruitment process in the Phase IIb study of the treatment of chorea in Huntington’s disease
SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligence platform (SOMAIPRO®), is pleased to announce that the recruitment of the Phase IIb clinical study with SOM3355 as a Read more…
0 Comments